Skip to main content

Free Content Field evaluation of clinical features during chikungunya outbreak in Mayotte, 2005–2006

Download Article:

You have access to the full text article on a website external to Ingenta Connect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

Summary Background 

To record and assess the clinical features of chikungunya fever (CHIKF), with a view to enable diagnosis based on clinical criteria rather than costly laboratory procedures in field conditions. Methods 

As part of a cross-sectional serologic survey conducted in Mayotte after a massive chikungunya outbreak in 2006, we collected data on clinical features of chikungunya infection and assessed the performance and accuracy of clinical case definition criteria combining different symptoms. Results 

Of 1154 participants included, 440 (38.1%) had chikungunya-specific IgM or IgG antibodies by enzyme-linked immunosorbent assay (ELISA). Of symptomatic participants, 318 (72.3%) had confirmed chikungunya, the dominant symptoms reported were incapacitating polyarthralgia (98.7%), myalgia (93.1%), backache (86%), fever of abrupt onset (85%) and headache (81.4%). There was a strong linear association between symptomatic infection and age (χ2 for trend = 9.85, P < 0.001). Only 52% of persons with presumptive chikungunya sought medical advice, principally at public primary health care facilities. The association of fever and polyarthralgia had a sensitivity of 84% (95% CI: 79–87) and a specificity of 89% (95% CI: 86–91). This association allowed to classify correctly 87% (95% CI: 85–89) of individuals with serologically confirmed chikungunya. Conclusions 

Our results suggest that the pair fever and incapacitating polyarthralgia is an accurate and reliable tool for identifying presumptive CHIKF cases in the field. These criteria provide a useful evidence base to support operational syndromic surveillance in laboratory-confirmed chikungunya epidemic settings.

Keywords: Chikungunya virus; Indian Ocean; Mayotte; clinical features; performance indicators

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1365-3156.2010.02485.x

Affiliations: 1:  Conseil Général de Mayotte, Direction de la Santé et de la PMI, Mamoudzou, Mayotte, France 2:  Centre Hospitalier de Mayotte, Laboratoire de Biologie, Mamoudzou, Mayotte, France 3:  Institut de Veille Sanitaire, Cellule interrégionale d’Epidémiologie de la Réunion, Mayotte, La Réunion, France

Publication date: May 1, 2010

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more